TickerFacts.

Karyopharm Therapeutics Inc. (KPTI): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$188.30M
Year ended 2019-12-31
2011-12-31: -$10.23M2012-12-31: -$15.77M2013-12-31: -$33.81M2014-12-31: -$75.52M2015-12-31: -$118.44M2016-12-31: -$110.02M2017-12-31: -$129.82M2018-12-31: -$179.15M2019-12-31: -$188.30M-$188.30M
2011-12-31 EBITDA (USD) 2019-12-31
Period endedEBITDAChange YoYSource filing
2019-12-31-$188.30Mn/m2022-03-01, From 2019-01-01
2018-12-31-$179.15Mn/m2021-02-24, From 2018-01-01
2017-12-31-$129.82Mn/m2020-02-26, From 2017-01-01
2016-12-31-$110.02Mn/m2019-02-28, From 2016-01-01
2015-12-31-$118.44Mn/m2018-03-15, From 2015-01-01
2014-12-31-$75.52Mn/m2017-03-16, From 2014-01-01
2013-12-31-$33.81Mn/m2016-03-15, From 2013-01-01
2012-12-31-$15.77Mn/m2015-03-13, From 2012-01-01
2011-12-31-$10.23Mn/a2014-03-21, From 2011-01-01